The drugs based on platinum metals represent one of the oldest, but also one of the most effective groups of chemotherapeutic agents. Thanks to many clinical studies it is known that resistance of tumor cells to drugs is a frequent cause of chemotherapy failure. With regard to platinum based drugs, multidrug resistance can also be connected with increased expression of low-molecular weight protein metallothionein (MT). This study aimed at investigating the interactions of MT with cisplatin or carboplatin, using the adsorptive transfer technique coupled with differential pulse voltammetry Brdicka reaction (AdTS DPV Brdicka reaction), and a comparison of in vitro results with results obtained in vivo. The results obtained from the in vitro study show a strong affinity between platinum based drugs and MT. Further, we analyzed extracts of neuroblastoma cell lines treated with cisplatin or carboplatin. It is clear that neuroblastoma UKF-NB-4 cisplatin-resistant and cisplatin-sensitive cell lines unlikely respond to the presence of the platinum-based cytostatics cisplatin and carboplatin. Finally, we determined the level of MT in samples from rabbits treated with carboplatin and patients with retinoblastoma treated with the same drug.

Department of Chemistry and Biochemistry Faculty of Agronomy Mendel University in Brno Zemedelska 1 CZ 613 00 Brno Czech Republic

Zobrazit více v PubMed

Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C. Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann. Oncol. 2008;19:631–640. PubMed

Levi F, Ferlay J, Galeone C, Lucchini F, Negri E, Boyle P, La Vecchia C. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int. 2008;101:949–958. PubMed

Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle P, La Vecchia C. Declining mortality from bladder cancer in Europe. BJU Int. 2008;101:11–19. PubMed

Zatonski WA, Manczuk M, Powles J, Negri E. Convergence of male and female lung cancer mortality at younger ages in the European Union and Russia. Eur. J. Public Health. 2007;17:450–454. PubMed

Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990. Eur. J. Cancer. 1997;33:1075–1107. PubMed

Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann. Oncol. 2005;16:481–488. PubMed

Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1995–1999, and an overview of trends since 1960. Int. J. Cancer. 2004;110:155–169. PubMed

Levi F, Lavecchia C, Lucchini F, Negri E. Cancer Mortality in Europe, 1990–92. Eur. J. Cancer Prev. 1995;4:389–417. PubMed

Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer. 2004;101:2843–2850. PubMed

Levi F, La Vecchia C, Negri E, Lucchini F. Childhood cancer mortality in Europe, 1955–1995. Eur. J. Cancer. 2001;37:785–809. PubMed

Okazaki Y, Namikawa K, Minami T. Studies of metals and metallothionein in tissue. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2000;120:282–289. PubMed

Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, Friedman C, Villegas E, Jacquemont C, Farrugia DJ, Couch FJ, Urban N, Taniguchi T. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature. 2008;451:1116–1119. PubMed PMC

Cavaletti G. Peripheral neurotoxicity of platinum-based chemotherapy. Nat. Rev. Cancer. 2008;8:1. PubMed

Damsma GE, Alt A, Brueckner F, Carell T, Cramer P. Mechanism of transcriptional stalling at cisplatin-damaged DNA. Nat. Struct. Mol. Biol. 2007;14:1127–1133. PubMed

Loehrer PJ, Einhorn LH. Drugs 5 years later - cisplatin. Ann. Intern. Med. 1984;100:704–713. PubMed

Sancar A. DNA excision repair. Annu. Rev. Biochem. 1996;65:43–81. PubMed

Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: The multidrug resistance-associated proteins. J. Natl. Cancer Inst. 2000;92:1295–1302. PubMed

Borst P, Evers R, Kool M, Wijnholds J. The multidrug resistance protein family. Biochim. Biophys. Acta-Biomembr. 1999;1461:347–357. PubMed

Siddik ZH. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265–7279. PubMed

Gately DP, Howell SB. Cellular Accumulation of the Anticancer Agent Cisplatin - a Review. Br. J. Cancer. 1993;67:1171–1176. PubMed PMC

Prestayko AW, Daoust JC, Issell BF, Crooke ST. Cisplatin (Cis-Diamminedichloroplatinum-Ii) Cancer Treat. Rev. 1979;6:17–39. PubMed

Rosenberg B, van Camp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature. 1965;205:698–699. PubMed

Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin. Cancer Res. 1998;4:1–6. PubMed

Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: A review of preclinical and clinical studies. Ann. Oncol. 1998;9:1053–1071. PubMed

Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 2005;4:307–320. PubMed

Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat. Res.-Fundam. Mol. Mech. Mutagen. 2001;478:23–43. PubMed

Weiss RB, Christian MC. New cisplatin analogs in development - a review. Drugs. 1993;46:360–377. PubMed

Go RS, Adjei AA. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J. Clin. Oncol. 1999;17:409–422. PubMed

Cohen SM, Lippard SJ. Progress in Nucleic Acid Research and Molecular Biology. Vol. 67. Academic Press Inc; San Diego, CA, USA: 2001. Cisplatin: From DNA damage to cancer chemotherapy; pp. 93–130. PubMed

Krizkova S, Adam V, Petrlova J, Zitka O, Stejskal K, Zehnalek J, Sures B, Trnkova L, Beklova M, Kizek R. A suggestion of electrochemical biosensor for study of platinum(II)-DNA interactions. Electroanalysis. 2007;19:331–338.

Sato M, Suzuki S. Endoplasmic reticulum stress and metallothionein. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2007;127:703–708. PubMed

Kerbel RS. Molecular origins of cancer: Tumor angiogenesis. N. Engl. J. Med. 2008;358:2039–2049. PubMed PMC

Adam V, Fabrik I, Eckschlager T, Stiborova M, Trnkova L, Kizek R. Vertebrate metallothioneins as target molecules for analytical techniques. TRAC-Trends Anal. Chem. 2010;29:409–418.

Adam V, Petrlova J, Wang J, Eckschlager T, Trnkova L, Kizek R. Zeptomole electrochemical detection of metallothioneins. PLoS ONE. 2010;5:e11441. PubMed PMC

Eckschlager T, Adam V, Hrabeta J, Figova K, Kizek R. Metallothioneins and cancer. Curr. Protein Pept. Sci. 2009;10:360–375. PubMed

Krizkova S, Fabrik I, Adam V, Hrabeta J, Eckschlager T, Kizek R. Metallothionein – a promising tool for cancer diagnostics. Bratisl. Med. J.-Bratisl. Lek. Listy. 2009;110:93–97. PubMed

Bell SG, Vallee BL. The metallothionein/thionein system: An oxidoreductive metabolic zinc link. ChemBioChem. 2009;10:55–62. PubMed

Haase H, Maret W. Partial oxidation and oxidative polymerization of metallothionein. Electrophoresis. 2008;29:4169–4176. PubMed

Li Y, Maret W. Human metallothionein metallomics. J. Anal. At. Spectrom. 2007;23:1055–1062.

Pedersen MO, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog. Histochem. Cytochem. 2009;44:29–64. PubMed

Miura N, Koizumi S. Heavy metal responses of the human metallothionein isoform genes. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2007;127:665–673. PubMed

Otsuka F, Ohno S, Suzuki K, Takahashi K, Ohsawa M, Koizumi S. Mechanism of metallothionein gene activation mediated by heavy-metal dependent transcription factor MTF-1. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2007;127:675–684. PubMed

Itoh N, Kimura T. Cytokine-induced metallothionein expression and modulation of cytokine expression by metallothionein. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2007;127:685–694. PubMed

Min KS. The physiological significance of metallothionein in oxidative stress. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2007;127:695–702. PubMed

Satoh M. Analysis of toxicity using metallothionein knockout mice. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2007;127:709–717. PubMed

Ohashi T, Satoh T, Kuwata M, Fujimura T, Taketani S. Visualization and evaluation of the promoter activities of genes for stress-inducible proteins in response to environmental pollutants. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2007;127:757–764. PubMed

Kaji T. Cell biology of heavy metal toxicity in vascular tissue. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2004;124:113–120. PubMed

Fabrik I, Krizkova S, Huska D, Adam V, Hubalek J, Trnkova L, Eckschlager T, Kukacka J, Prusa R, Kizek R. Employment of electrochemical techniques for metallothionein determination in tumor cell lines and patients with a tumor disease. Electroanalysis. 2008;20:1521–1532.

Adam V, Baloun J, Fabrik I, Trnkova L, Kizek R. An electrochemical detection of metallothioneins at the zeptomole level in nanolitre volumes. Sensors. 2008;8:2293–2305. PubMed PMC

Adam V, Hanustiak P, Krizkova S, Beklova M, Zehnalek J, Trnkova L, Horna A, Sures B, Kizek R. Palladium biosensor. Electroanalysis. 2007;19:1909–1914.

Adam V, Krizkova S, Zitka O, Trnkova L, Petrlova J, Beklova M, Kizek R. Determination of apo-metallothionein using adsorptive transfer stripping technique in connection with differential pulse voltammetry. Electroanalysis. 2007;19:339–347.

Petrlova J, Potesil D, Mikelova R, Blastik O, Adam V, Trnkova L, Jelen F, Prusa R, Kukacka J, Kizek R. Attomole voltammetric determination of metallothionein. Electrochim. Acta. 2006;51:5112–5119.

Adam V, Petrlova J, Potesil D, Zehnalek J, Sures B, Trnkova L, Jelen F, Kizek R. Study of metallothionein modified electrode surface behavior in the presence of heavy metal ions-biosensor. Electroanalysis. 2005;17:1649–1657.

Hou XF, Fan QX, Wang LX, Lu SX. Role of metallothionein1h in cisplatin resistance of non-small cell lung cancer cells. Chin. J. Cancer Res. 2009;21:247–254.

Krizkova S, Adam V, Eckschlager T, Kizek R. Using of chicken antibodies for metallothionein detection in human blood serum and cadmium-treated tumor cell lines after dot- and electroblotting. Electrophoresis. 2009;30:3726–3735. PubMed

Erk M, Ivankovic D, Raspor B, Pavicic J. Evaluation of different purification procedures for the electrochemical quantification of mussel metallothioneins. Talanta. 2002;57:1211–1218. PubMed

Adam V, Beklova M, Pikula J, Hubalek J, Trnkova L, Kizek R. Shapes of differential pulse voltammograms and level of metallothionein at different animal species. Sensors. 2007;7:2419–2429. PubMed PMC

Adam V, Blastik O, Krizkova S, Lubal P, Kukacka J, Prusa R, Kizek R. Application of the Brdicka reaction in determination of metallothionein in patients with tumours. Chem. Listy. 2008;102:51–58.

Diopan V, Shestivska V, Adam V, Macek T, Mackova M, Havel L, Kizek R. Determination of content of metallothionein and low molecular mass stress peptides in transgenic tobacco plants. Plant Cell Tissue Organ Cult. 2008;94:291–298.

Fabrik I, Ruferova Z, Hilscherova K, Adam V, Trnkova L, Kizek R. A determination of metallothionein in larvae of freshwater midges (Chironomus riparius) using Brdicka reaction. Sensors. 2008;8:4081–4094. PubMed PMC

Krizkova S, Blahova P, Nakielna J, Fabrik I, Adam V, Eckschlager T, Beklova M, Svobodova Z, Horak V, Kizek R. Comparison of metallothionein detection by using brdicka reaction and enzyme-linked immunosorbent assay employing chicken yolk antibodies. Electroanalysis. 2009;21:2575–2583.

Huska D, Fabrik I, Baloun J, Adam V, Masarik M, Hubalek J, Vasku A, Trnkova L, Horna A, Zeman L, Kizek R. Study of interactions between metallothionein and cisplatin by using differential pulse voltammetry brdicka’s reaction and quartz crystal microbalance. Sensors. 2009;9:1355–1369. PubMed PMC

El Hourch M, Dudoit A, Amiard JC. An optimization procedure for determination of metallothionein by square wave cathodic stripping voltammetry: Application to marine worms. Anal. Bioanal. Chem. 2004;378:776–781. PubMed

Supalkova V, Petrek J, Baloun J, Adam V, Bartusek K, Trnkova L, Beklova M, Diopan V, Havel L, Kizek R. Multi-instrumental investigation of affecting of early somatic embryos of Spruce by cadmium(II) and lead(II) ions. Sensors. 2007;7:743–759.

Zinc and zinc-containing biomolecules in childhood brain tumors